Nano cap Heat Biologics (HTBX +13.9%) jumps on a healthy 12x surge in volume in reaction to its collaboration with the University of Miami Miller School of Medicine aimed at developing a coronavirus vaccine.
The company says the COVID-19 vaccine will
leverage its gp96 platform to generate open docking sites for the
insertion of multiple SARS-CoV-2 antigens, adding that its approach
should activate a potent immune response without the disadvantages of
possible genomic integration of foreign DNA or viral vector instability
possible with attenuated viral vaccines.
Subsidiary Zolovax will lead development.
https://seekingalpha.com/news/3549068-heat-biologics-up-14-on-coronavirus-vaccine-plan
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.